Clinical Trial Update: A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of DSP-7888 in pediatric patients with relapsed or refractory high-grade gliomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Glioblastoma

Drugs mentioned

• DSP-7888

Snippet

Sponsor: Sumitomo Pharma Co., Ltd. | Conditions: Glioblastoma, Diffuse Intrinsic Pontine Glioma | Phase 1, Phase 2 | Status: COMPLETED